Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 637, doi. 10.3390/ph8030637
- By:
- Publication type:
- Article
Works matching IS 14248247 AND DT 2015 AND VI 8 AND IP 3
Results: 26
1
2
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 607, doi. 10.3390/ph8030607
- By:
- Publication type:
- Article
3
Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 590, doi. 10.3390/ph8030590
- By:
- Publication type:
- Article
4
Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 559, doi. 10.3390/ph8030559
- By:
- Publication type:
- Article
5
Ecology of Anti-Biofilm Agents I: Antibiotics versus Bacteriophages.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 525, doi. 10.3390/ph8030525
- By:
- Publication type:
- Article
6
Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 512, doi. 10.3390/ph8030512
- By:
- Publication type:
- Article
7
Prospects for Anti-Biofilm Pharmaceuticals.
- Published in:
- 2015
- By:
- Publication type:
- Opinion
8
Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida Species.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 483, doi. 10.3390/ph8030483
- By:
- Publication type:
- Article
9
UCP2 Modulates Cardioprotective Effects of Ru360 in Isolated Cardiomyocytes during Ischemia.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 474, doi. 10.3390/ph8030474
- By:
- Publication type:
- Article
10
On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 455, doi. 10.3390/ph8030455
- By:
- Publication type:
- Article
11
Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 435, doi. 10.3390/ph8030435
- By:
- Publication type:
- Article
12
Toxicological Studies of <sup>212</sup>Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 416, doi. 10.3390/ph8030416
- By:
- Publication type:
- Article
13
Peptides and Peptidomimetics for Antimicrobial Drug Design.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 366, doi. 10.3390/ph8030366
- By:
- Publication type:
- Article
14
Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 637, doi. 10.3390/ph8030637
- By:
- Publication type:
- Article
15
Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 607, doi. 10.3390/ph8030607
- By:
- Publication type:
- Article
16
Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 590, doi. 10.3390/ph8030590
- By:
- Publication type:
- Article
17
Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 559, doi. 10.3390/ph8030559
- By:
- Publication type:
- Article
18
Ecology of Anti-Biofilm Agents I: Antibiotics versus Bacteriophages.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 525, doi. 10.3390/ph8030525
- By:
- Publication type:
- Article
19
Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 512, doi. 10.3390/ph8030512
- By:
- Publication type:
- Article
20
Prospects for Anti-Biofilm Pharmaceuticals.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 504, doi. 10.3390/ph8030504
- By:
- Publication type:
- Article
21
Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida Species.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 483, doi. 10.3390/ph8030483
- By:
- Publication type:
- Article
22
UCP2 Modulates Cardioprotective Effects of Ru360 in Isolated Cardiomyocytes during Ischemia.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 474, doi. 10.3390/ph8030474
- By:
- Publication type:
- Article
23
On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 455, doi. 10.3390/ph8030455
- By:
- Publication type:
- Article
24
Bench to Bedside: Stability Studies of GMP Produced Trastuzumab-TCMC in Support of a Clinical Trial.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 435, doi. 10.3390/ph8030435
- By:
- Publication type:
- Article
25
Toxicological Studies of <sup>212</sup>Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 416, doi. 10.3390/ph8030416
- By:
- Publication type:
- Article
26
Peptides and Peptidomimetics for Antimicrobial Drug Design.
- Published in:
- Pharmaceuticals (14248247), 2015, v. 8, n. 3, p. 366, doi. 10.3390/ph8030366
- By:
- Publication type:
- Article